Last reviewed · How we verify
Saquinavir, lopinavir, ritonavir
Saquinavir, lopinavir, ritonavir is a Small molecule drug developed by The HIV Netherlands Australia Thailand Research Collaboration. It is currently in Phase 2 development.
At a glance
| Generic name | Saquinavir, lopinavir, ritonavir |
|---|---|
| Sponsor | The HIV Netherlands Australia Thailand Research Collaboration |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV (PHASE2, PHASE3)
- Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy (PHASE3)
- Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients (PHASE2)
- Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children (PHASE2, PHASE3)
- A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy (PHASE2)
- Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV (PHASE1, PHASE2)
- Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants (PHASE3)
- IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Saquinavir, lopinavir, ritonavir CI brief — competitive landscape report
- Saquinavir, lopinavir, ritonavir updates RSS · CI watch RSS
- The HIV Netherlands Australia Thailand Research Collaboration portfolio CI
Frequently asked questions about Saquinavir, lopinavir, ritonavir
What is Saquinavir, lopinavir, ritonavir?
Saquinavir, lopinavir, ritonavir is a Small molecule drug developed by The HIV Netherlands Australia Thailand Research Collaboration.
Who makes Saquinavir, lopinavir, ritonavir?
Saquinavir, lopinavir, ritonavir is developed by The HIV Netherlands Australia Thailand Research Collaboration (see full The HIV Netherlands Australia Thailand Research Collaboration pipeline at /company/the-hiv-netherlands-australia-thailand-research-collaboration).
What development phase is Saquinavir, lopinavir, ritonavir in?
Saquinavir, lopinavir, ritonavir is in Phase 2.